Vivo Capital’s ChemoCentryx, Inc. CCXI Stock Holding History

Vivo Capital’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-887,906	Closed	-$2.21M	–	24
2016 Q1	$2.21M	Buy	+887,906	New	+$3.23M	0.55%	19

Other funds holding CCXI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vivo Capital's CCXI Position: Q2 2016 in Review

Vivo Capital sold out of ChemoCentryx, Inc. (CCXI) in Q2 2016, closing a stake of 887,906 shares — an estimated $2.21M sold.

Vivo Capital first reported a position in CCXI in Q1 2016 and held it in 1 quarter. The position peaked at $2.21M in Q1 2016. 77 funds tracked by Wall St. Rank hold CCXI as of Q2 2016.

Vivo Capital reported no remaining ChemoCentryx, Inc. position as of Q2 2016 after selling out during the quarter.
Vivo Capital sold 887,906 ChemoCentryx, Inc. shares in Q2 2016, an estimated $2.21M.
Vivo Capital first reported a position in ChemoCentryx, Inc. in Q1 2016 and held it in 1 quarter.
Vivo Capital's ChemoCentryx, Inc. position peaked at $2.21M in Q1 2016.
77 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2016.

Based on Vivo Capital's 13F filing for Q2 2016, filed 15 Aug 2016.